DK1459739T3 - Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer - Google Patents

Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Info

Publication number
DK1459739T3
DK1459739T3 DK03006160T DK03006160T DK1459739T3 DK 1459739 T3 DK1459739 T3 DK 1459739T3 DK 03006160 T DK03006160 T DK 03006160T DK 03006160 T DK03006160 T DK 03006160T DK 1459739 T3 DK1459739 T3 DK 1459739T3
Authority
DK
Denmark
Prior art keywords
hydroscopic
quinoline carboxylic
pharmaceutical compositions
carboxylic acids
compositions containing
Prior art date
Application number
DK03006160T
Other languages
English (en)
Inventor
Adnan Dr Badwan
Lina Najati Nabulsi
Mahmoud M Omari
Original Assignee
Jordanian Pharmaceutical Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jordanian Pharmaceutical Mfg filed Critical Jordanian Pharmaceutical Mfg
Application granted granted Critical
Publication of DK1459739T3 publication Critical patent/DK1459739T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK03006160T 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer DK1459739T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03006160A EP1459739B1 (en) 2003-03-19 2003-03-19 Non-hygroscopic pharmaceutical compositions containing non-hydrated quinoline carboxylic acids

Publications (1)

Publication Number Publication Date
DK1459739T3 true DK1459739T3 (da) 2008-05-19

Family

ID=32798836

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03006160T DK1459739T3 (da) 2003-03-19 2003-03-19 Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer

Country Status (7)

Country Link
US (1) US20040224014A1 (da)
EP (1) EP1459739B1 (da)
JP (1) JP2004339198A (da)
AT (1) ATE382338T1 (da)
DE (1) DE60318384T2 (da)
DK (1) DK1459739T3 (da)
ES (1) ES2297067T3 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384333T3 (es) * 2005-04-11 2012-07-03 Abbott Laboratories Composiciones farmacéuticas que tienen perfiles de disolución mejorados para fármacos poco solubles
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2594272B1 (en) * 2005-05-18 2018-07-11 Horizon Orphan LLC Aerosolized fluoroquinolones and uses thereof
PL2101733T3 (pl) 2006-12-13 2013-02-28 Hoffmann La Roche Preparat w postaci proszku walgancyklowiru
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
KR101959873B1 (ko) 2008-10-07 2019-03-19 랩터 파마슈티컬스 인코포레이티드 약동학 개선을 위한 에어로졸 플루오로퀴놀론 제형
WO2011029059A1 (en) 2009-09-04 2011-03-10 Mpex Pharmaceuticals, Inc. Use of aerosolized levofloxacin for treating cystic fibrosis
RU2633477C2 (ru) * 2011-11-30 2017-10-12 Тояма Кемикал Ко., Лтд. Таблетка, содержащая гидрат метансульфоната 1-циклопропил-8-(дифторметокси)-7-[(1r)-1-метил-2, 3-дигидро-1н-изоиндол-5-ил]-4-оксо-1, 4-дигидрохинолин-3-карбоновой кислоты
CA2910112C (en) 2013-04-25 2021-02-16 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
US9687453B2 (en) 2013-04-25 2017-06-27 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
US10154993B2 (en) 2014-10-23 2018-12-18 Kyorin Pharmaceutical Co., Ltd. Solid pharmaceutical composition
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
CN107115312A (zh) * 2017-05-17 2017-09-01 湖南新汇制药股份有限公司 一种诺氟沙星片及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
CA2227314A1 (en) * 1997-01-24 1998-07-24 Hoechst Aktiengesellschaft Preparation of concealed taste preparations of antibacterially active quinolone derivatives
PA8466701A1 (es) * 1998-01-21 2000-09-29 Pfizer Prod Inc Comprimido de mesilato de trovafloxacino
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
IT1319664B1 (it) * 2000-11-17 2003-10-23 Pharma Biotech Ltd Addotti di antibatterici chinolonici con polimeri polisaccaridicinaturali.

Also Published As

Publication number Publication date
US20040224014A1 (en) 2004-11-11
JP2004339198A (ja) 2004-12-02
EP1459739B1 (en) 2008-01-02
DE60318384T2 (de) 2009-02-19
ATE382338T1 (de) 2008-01-15
ES2297067T3 (es) 2008-05-01
DE60318384D1 (de) 2008-02-14
EP1459739A1 (en) 2004-09-22

Similar Documents

Publication Publication Date Title
DK1459739T3 (da) Ikke-hydroskopiske farmaceutiske sammensætninger indeholdende ikke-hydratiserede quinolin-carboxylsyrer
ATE376423T1 (de) Gelierende wässrige pharmazeutische zusammensetzungen
ATE500818T1 (de) Kalziumatorvastatin enthaltende arzneiformulierung
CY2015045I1 (el) Φαρμακευτικες συνθεσεις ελεγχομενης απελευθερωσης που περιλαμβανουν εστερα φουμαρικου οξεος
EP1343805A4 (en) COMPOUNDS DERIVED FROM GALLENIC ACIDS FOR THE PROVISION OF CONTINUING SYSTEMIC CONCENTRATIONS OF MEDICINAL PRODUCTS AFTER ORAL ADMINISTRATION
EP2036565A4 (en) PREPARATION FOR EXTERNAL APPLICATION TO THE SKIN WITH TRITERPENIC ACID
DK1396270T3 (da) Borsyresalte
ATE420638T1 (de) Stabile feste medizinische zusammensetzung für die orale verabreichung von ramosetron
DE60025503D1 (de) Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten
EP1584320A4 (en) COSMETIC COMPOSITION WITH GLYCERYLAMINO-ACID DERIVATIVES
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
BR0311642A (pt) Formulação de divalproex de sódio de liberação aumentada
NO20021898D0 (no) Farmasöytisk sammensetning inneholdende ciclesonid for applikasjon til mukosa
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
WO2008020314A3 (en) Statin stabilizing dosage formulations
DK1666473T3 (da) Carboxylsyreforbindelser og medicinske sammensætninger indeholdende samme som aktiv ingrediens
ATE378335T1 (de) Chirale fluorochinolizinon arginine salze
EP1830831A4 (en) PHARMACEUTICAL FORMULATIONS OF GALLIUM SALTS
CO6270204A2 (es) Soluciones farmaceuticas orales que contienen telbivudina
DE60143052D1 (de) Lipid vom carbonsäuretyp
IL174248A0 (en) Alkyl carboxylic acid derivatives and pharmaceutical compositions containing the same
UA94955C2 (en) Aqueous pharmaceutical formulation of 4-[((4-carboxybutyl)-{2-[(4-phenethyl-benzyl)oxy]-phenethyl}amino)methyl] benzoic acid
JO2567B1 (en) Non-water-absorbing pharmaceutical formula containing non-hydrated carboxylic quinoline acids
EP1858841A4 (en) COMPOSITION FOR STERILIZATION COMPRISING w-ALKOXYPEROXYCARBOXYLIC ACID
EE200300112A (et) D-pantoteenhapet ja/või selle sooli sisaldav loomasöödalisand, saamismeetod, kasutamine